You have 9 free searches left this month | for more free features.

No standard treatment available

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

Available
  • Clear Cell Kidney Cancer
  • +2 more
  • Axitinib 5 MG
  • (no location specified)
Jul 3, 2023

Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available Trial

Completed
  • Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available
  • Houston, Texas
    M.D. Anderson Cancer Center
Aug 22, 2022

Tumor, Solid, Gall Bladder Cancer, Cervical Cancer Trial in Santiago, Vina del Mar (Andes-1537 for Injection)

Completed
  • Tumor, Solid
  • +5 more
  • Andes-1537 for Injection
  • Santiago, Region Metropolitana, Chile
  • +3 more
Feb 23, 2022

Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and

Completed
  • Leukemia
  • No Intervention
  • Cambridge, Massachusetts
    Takeda
Feb 28, 2023

Skin Hydration in Healthy Volunteers Trial in Northfield (Marathon® XL No Sting Cyanoacrylate Skin Protectant and 3M™ Cavilon™

Completed
  • Skin Hydration in Healthy Volunteers
  • Marathon® XL No Sting Cyanoacrylate Skin Protectant and 3M™ Cavilon™ Advanced Skin Protectant
  • Northfield, Illinois
    Medline Industries, LP
Feb 23, 2023

Available for Members Text Message, Checked Health Text Message, No Text Message Trial in Philadelphia (Impact of Nudges on CKD

Active, not recruiting
  • Available for Members Text Message
  • +2 more
  • Impact of Nudges on CKD Testing
  • Philadelphia, Pennsylvania
    Center for Health Incentives and Behavioral Economics (CHIBE)
Jul 15, 2022

NSCLC Trial (Atezolizumab, Tiragolumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Apr 11, 2023

Acute Myeloid Leukemia Trial in Paris (Hematopoietic stem cell transplantation, Best chemo treatment)

Recruiting
  • Acute Myeloid Leukemia
  • Hematopoietic stem cell transplantation
  • Best chemotherapy treatment
  • Paris, France
    Saint Antoine Hospital - Hematology Department
Jan 24, 2022

Asthma COPD Trial in Birmingham (Wheeze measurement)

Recruiting
  • Asthma COPD
  • Wheeze measurement
  • Birmingham, West Midlands, United Kingdom
    University Hospitals Birmingham NHS Foundation Trust
Sep 14, 2023

Lymphomas Trial in Wuhan, Guangzhou, Shanghai (HMPL-689)

Active, not recruiting
  • Lymphomas
  • Wuhan, Hubei, China
  • +2 more
Sep 8, 2022

Squamous Cell Carcinoma Trial in New York (Standard surveillance, Telemedicine surveillance (tele-surveillance), Questionnaires)

Recruiting
  • Squamous Cell Carcinoma
  • Standard surveillance
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 17, 2022

6 Months Adjuvant Temozolomide vs No Adjuvant TMZ in Newly

Withdrawn
  • MGMT-Methylated Glioblastoma
  • Delay of TMZ
  • Standard of Care (SOC) Adjuvant TMZ (no intervention
  • (no location specified)
Aug 5, 2022

ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention, No-Reflow Phenomenon Trial in Tomsk (Standard therapy,

Active, not recruiting
  • ST Elevation Myocardial Infarction
  • +2 more
  • Standard therapy
  • +3 more
  • Tomsk, Tomsk Region, Russian Federation
    Cardiology Research Institute, Tomsk NRMC
Oct 31, 2022

Postoperative Pain, Opioid Use, Prolapse; Female Trial in Cleveland (Standard opioid prescribing, Restrictive opioid

Active, not recruiting
  • Postoperative Pain
  • +3 more
  • Standard opioid prescribing
  • Restrictive opioid prescribing
  • Cleveland, Ohio
    Cleveland Clinic
Jul 11, 2022

Pelvic Floor Disorders Trial in Cleveland (Pelvic Floor Physical Therapy (PFPT), No Pelvic Floor Physical Therapy (PFPT),

Completed
  • Pelvic Floor Disorders
  • Pelvic Floor Physical Therapy (PFPT)
  • +3 more
  • Cleveland, Ohio
    Cleveland Clinic
Jan 19, 2023

Stress Trial in New York (Personalized Trial ABCCBA, Personalized Trial CBAABC, Stress Management Techniques with No

Recruiting
  • Stress
  • Personalized Trial ABCCBA
  • +2 more
  • New York, New York
    Institute of Health System Science
Dec 2, 2022

No-Reflow Phenomenon Trial (Alpha Lipoic Acid plus the standard care for post-PCI MI, The standard care for post-PCI MI)

Not yet recruiting
  • No-Reflow Phenomenon
  • Alpha Lipoic Acid plus the standard care for post-PCI MI
  • The standard care for post-PCI MI
  • (no location specified)
Apr 29, 2022

Solid Tumor Trial in Duarte (RNR inhibitor COH29, laboratory biomarker analysis, pharmacological study)

Suspended
  • Unspecified Adult Solid Tumor, Protocol Specific
  • RNR inhibitor COH29
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

COVID-19, Sars-CoV2, Cancer Trial in Augusta, Columbus (TL-895)

Completed
  • COVID-19
  • +5 more
  • Augusta, Georgia
  • +1 more
May 10, 2021

COVID-19 Trial in Bilthoven (Customised testing advice, Regular testing advice, LFT available)

Completed
  • COVID-19
  • Customised testing advice
  • +3 more
  • Bilthoven, Utrecht, Netherlands
    National Institute for Public Health and the Environment
Jan 28, 2022

Oropharyngeal Cancer Trial in Canada (Radiation, Cisplatin)

Active, not recruiting
  • Oropharyngeal Cancer
  • Prince George, British Columbia, Canada
  • +13 more
Dec 12, 2022

Colorectal Cancer, Colon Cancer Trial in Philadelphia (Differentiated Box, Standard Mail, Text)

Completed
  • Colorectal Cancer
  • Colon Cancer
  • Differentiated Box
  • +5 more
  • Philadelphia, Pennsylvania
    Penn Medicine
Jan 27, 2023

Small-cell Lung Cancer Trial in United States (HPN328)

Recruiting
  • Small-cell Lung Cancer
  • Aurora, Colorado
  • +9 more
Jan 11, 2022

COVID-19 Trial in Russian Federation (Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate intramuscularly,

Completed
  • COVID-19
  • Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate intramuscularly
  • +2 more
  • Cheboksary, Russian Federation
  • +9 more
Dec 19, 2022

Hip Dysplasia, Hip Injuries, Hip Fractures Trial (Pericapsular nerve group block using 0.2% ropivacaine, Erector Spinae Plane

Not yet recruiting
  • Hip Dysplasia
  • +3 more
  • Pericapsular nerve group block using 0.2% ropivacaine
  • +2 more
  • (no location specified)
Oct 11, 2023